Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies
Summary
  • For a short-term investment strategy, the company has poor fundamentals.
Strengths
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The tendency within the weekly time frame is positive above the technical support level at 44.08 USD
Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
  • Technically, the stock approaches a strong medium-term resistance at USD 50.85.
  • The company's enterprise value to sales, at 3.84 times its current sales, is high.
  • With an expected P/E ratio at 45.77 and 27.93 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart
Subsector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
ABBOTT LABORATORIES27.10%86 542
JOHNSON & JOHNSON15.77%360 112
NOVARTIS10.12%220 515
ROCHE HOLDING LTD.5.33%218 264
PFIZER2.71%198 663
MERCK AND COMPANY6.51%171 005
SANOFI7.39%122 810
BAYER9.05%105 305
GLAXOSMITHKLINE-3.71%95 424
BRISTOL-MYERS SQUIBB COMPAN..-0.98%94 296
NOVO NORDISK A/S13.47%88 914
Autres valeurs du secteur
Company
Engages in the discovery, development, manufacture and sale of health care productsAbbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products.It operates through the following segments: Established Pharmaceutical Products,... 
Sector
Pharmaceuticals
Calendar
10/18Earnings Release
Financials ($)
Sales 2017 26 470 M
EBIT 2017 5 762 M
Net income 2017 2 348 M
Debt 2017 14 982 M
Yield 2017 2,16%
P/E ratio 2017 45,77
P/E ratio 2018 27,93
EV / Sales 2017 3,84x
EV / Sales 2018 3,56x
Capitalization 86 542 M
Chart ABBOTT LABORATORIES
Duration : Period : Day
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | 4-Traders
Duration : Period : Week
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | 4-Traders
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes